LD Micro Invitational Archives

WednesdayJun 05, 2019 3:40 pm

CytoDyn Inc. (CYDY) Starts Presentation at 9th Annual LD Micro Invitational

CytoDyn (OTCQB: CYDY) is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells. The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The company plans to seek FDA approval for PRO 140 in combination therapy and…

WednesdayJun 05, 2019 3:40 pm

Eastside Distilling Inc. (NASDAQ: EAST) Starts Presentation at 9th Annual LD Micro Invitational

Eastside Distilling (NASDAQ: EAST) has been producing high-quality, award-winning craft spirits since 2008. The company is distinguished by its highly decorated product lineup that includes Burnside Bourbon, West End American Whiskey, Goose Hollow Reserve, Below Deck Rums, Portland Potato Vodka, Hue-Hue Coffee Rum and a distinctive line of fruit infused spirits. Eastside Distilling is majority owner of Big Bottom and the Redneck Riviera Whiskey Co. All Eastside, Big Bottom and Redneck Riviera spirits are crafted from natural ingredients for quality and taste. Eastside’s Mother Lode Bottling subsidiary is one of the Northwest’s leading independent spirit bottlers and ready-to-drink canners. For…

WednesdayJun 05, 2019 3:00 pm

Wize Pharma Inc. (WIZP) Starts Presentation at 9th Annual LD Micro Invitational

Wize Pharma (OTCQB: WIZP) is a clinical-stage biopharmaceutical company currently focused on the treatment of ophthalmic disorders, including DES. Wize has in-licensed certain rights to purchase, market, sell and distribute a formula known as LO2A, a drug developed for the treatment of DES, and other ophthalmological illnesses, including CCh and Sjögren's syndrome (Sjögren's). Wize's strategy involves engaging local or multinational distributors to handle the distribution of LO2A. Wize has finished a Phase II trial of LO2A for patients with CCH and is currently conducting a phase IV study for LO2A for DES in patients with Sjögren's. For more information, visit…

WednesdayJun 05, 2019 3:00 pm

U.S. Nuclear Corp. (UCLE) Starts Presentation at 9th Annual LD Micro Invitational

US Nuclear (OTC: UCLE) is a radiation and chemical detection holding company specializing in the development and manufacturing and sales of radiation and chemical detection instrumentation. Through three operating divisions (Technical Associates (TA), Overhoff Technology (OTC), and Electronic Control Concepts (ECC), US Nuclear Corp. has more than 100 years of combined experience in supplying instrumentation to any industry utilizing radionuclides. This includes nuclear power plants, national laboratories, government agencies, homeland security, military, universities and schools, research companies, hospitals, medical and dental centers, energy companies, weapons facilities, first responders, local governments, and manufacturing plants. For more information, visit the company's website…

WednesdayJun 05, 2019 2:40 pm

Youngevity International Inc. (NASDAQ: YGYI) Starts Presentation at 9th Annual LD Micro Invitational

Youngevity International (NASDAQ: YGYI) is an omni-direct lifestyle company offering a hybrid of the direct selling business model, that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, YGYI offers products from the eight top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, fashion, essential oils, photo, as well as innovative services. The company was formed in the course of the summer 2011 merger of Youngevity Essential Life Sciences with Javalution Coffee Company (now part of the company’s food and beverage division). For more information, visit…

WednesdayJun 05, 2019 2:40 pm

Nymox Pharmaceutical Corp. (NASDAQ: NYMX) Starts Presentation at 9th Annual LD Micro Invitational

Nymox Pharmaceutical (NASDAQ: NYMX) specializes in the research and development of therapeutics and diagnostics, with an emphasis on products targeted for the unmet needs of the rapidly aging male population in developed economies. The company’s lead drug candidate for benign prostatic hyperplasia (BPH) Fexapotide Triflutate (FT) has completed phase 3 development in more than 70 clinical centers in the United States, involving more than 1700 patients during the entire clinical development program. The company will soon be filing for approval in major economies around the world, including the United States and Europe. In addition, the Company is developing Fexapotide for…

WednesdayJun 05, 2019 2:40 pm

SinglePoint Inc. (SING) Starts Presentation at 9th Annual LD Micro Invitational

SinglePoint (OTCQB: SING) is a technology and investment vehicle focused on acquiring companies that will immediately benefit from the injection of technology integration and growth capital. Through acquisitions into horizontal markets, SinglePoint has been successful in building its portfolio by acquiring an interest in undervalued equities, thereby developing a rich, diversified portfolio base. The company holdings currently include mobile payments, ancillary cannabis products/services via SingleSeed, and blockchain solutions. For more information, visit the company's website at www.singlepoint.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via…

WednesdayJun 05, 2019 2:40 pm

CURE Pharmaceutical Holding (CURR) Starts Presentation at 9th Annual LD Micro Invitational

CURE Pharmaceutical (OTCQB: CURR) is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and the patient experience through its proprietary drug dosage forms and delivery systems. CURE has a full-service cGMP manufacturing facility and is a pioneering developer and manufacturer of a patented and proprietary delivery system (CUREfilm), one of the most advanced oral thin films on the market today. CURE is developing an array of products in innovative delivery platforms and partners with biotech and pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships…

WednesdayJun 05, 2019 2:40 pm

Relmada Therapeutics (RLMD) Starts Presentation at 9th Annual LD Micro Invitational

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage biotechnology company developing novel medicines that potentially address areas of high unmet medical need in the treatment of central nervous system (CNS) diseases. Relmada's lead program, dextromethadone (REL-1017), is an N-methyl-D-aspartate (NMDA) receptor antagonist. NMDA receptor antagonists may have potential in the treatment of a range of psychiatric and neurological disorders associated with a variety of cognitive, neurological and behavioral symptoms. For more information, visit the company's website at www.relmada.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via…

WednesdayJun 05, 2019 2:40 pm

trutankless (TKLS) Starts Presentation at 9th Annual LD Micro Invitational

trutankless (OTCQB: TKLS) modernizes tankless water heating by promoting energy conservation and long-term savings with its revolutionary product for the benefit of homeowners, service professionals and consumers. Trutankless is engaged in manufacturing electric tankless water heaters that far surpasses traditional tank water heaters in energy efficiency, output, dependability and environmental sustainability. The company's patented products include WiFi capabilities to help modernize the water heating industry. The Trutankless brand mission is to apply smart engineering to forward-thinking technologies that save customers money, energy, and space. For more information, visit the company's website at www.trutanklessinc.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Category: LD Micro Invitational

CytoDyn Inc. (CYDY) Starts Presentation at 9th Annual LD Micro Invitational

Eastside Distilling Inc. (NASDAQ: EAST) Starts Presentation at 9th Annual LD Micro Invitational

Wize Pharma Inc. (WIZP) Starts Presentation at 9th Annual LD Micro Invitational

U.S. Nuclear Corp. (UCLE) Starts Presentation at 9th Annual LD Micro Invitational

Youngevity International Inc. (NASDAQ: YGYI) Starts Presentation at 9th Annual LD Micro Invitational

Nymox Pharmaceutical Corp. (NASDAQ: NYMX) Starts Presentation at 9th Annual LD Micro Invitational

SinglePoint Inc. (SING) Starts Presentation at 9th Annual LD Micro Invitational

CURE Pharmaceutical Holding (CURR) Starts Presentation at 9th Annual LD Micro Invitational

Relmada Therapeutics (RLMD) Starts Presentation at 9th Annual LD Micro Invitational

trutankless (TKLS) Starts Presentation at 9th Annual LD Micro Invitational

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search